Dual inhibition of DYRK1A and MYC increases apoptosis in certain KMT2A-R ALL cell lines but does not consistently enhance the therapeutic efficacy of DYRK1A inhibition. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.